DNLI
Denali Therapeutics Inc.Healthcare$20.65
◆ Neutral
Mkt Cap: $3.27B|Float: 144.4M|SI: 9.9%|DTC: 9.0
Data as of market close Apr 2, 2026
IV Rank
42
IV Pctl
56%
HV 20d
79.0%
52W Range
$11-$24
ATR(14)
$1.25
Exp. Move
±11.0%
P/C Ratio
0.51
Earnings
May 11
GEX Positive
DEX Long
Net Put Premium
IV Moderate
Max Pain Below
Exp. Move Wide
Low Put/Call
DNLI Key Options Data
- IV Rank
- 41.6%
- Total GEX
- $0.00B
- Total DEX
- $0.4M
- Max Pain
- $20.00
- Expected Move
- ±11.0%
- Put/Call OI
- 0.51
- Net Premium
- $-0.1M
- Spot Price
- $20.65
Gamma Exposure (GEX)
Delta Exposure (DEX)
Expected Move by Expiration
| Expiration | DTE | Expected Move | Move % | Lower | Upper |
|---|---|---|---|---|---|
| 2026-04-17 | 15 | ±$2.27 | ±11.0% | $18.37 | $22.92 |
| 2026-05-15 | 43 | ±$4.42 | ±21.4% | $16.22 | $25.07 |
| 2026-06-18 | 77 | ±$6.12 | ±29.7% | $14.52 | $26.77 |
| 2026-09-18 | 169 | ±$8.98 | ±43.5% | $11.67 | $29.62 |
Explore DNLI options data including implied volatility rankings, gamma and delta exposure, max pain levels, and expected price moves. AI-generated reports provide directional, income, and earnings analysis.